Published by Josh White on 15th December 2017
(ShareCast News) - Hutchison China MediTech, known as Chi-Med, has initiated the United States Phase I bridging clinical trial of fruquintinib, it announced on Friday.
URL: http://www.digitallook.com/dl/news/story/26834698/...